Intravenous Versus Peribulbar Dexmedetomidine for Strabismus Surgery in Adults

• Status: Not yet recruiting
• Trial end date: 2022-06-20
• Target enrollment: 0
• Participant gender: All

Summary

Using various adjuvants has become a trend in regional anesthesia practice to improve the quality of anesthesia and prolong postoperative analgesia. Dexmedetomidine, an alpha-2 agonist has been proposed as a safe and effective adjunct capable of extending the duration of the single-shot block

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

1. The patients planned to perform a unilateral strabismus surgery

2. Age: 20-60 years

3. American Society of Anesthesiologists class I and II

Exclusion Criteria:

1. patients under the age of 20

2. Patients have systemic or bleeding disorders

3. Patients with ocular or neurological problems, mental retardation, deafness, or dementia

4. patients who disincline to participate in the study will be excluded from the study